Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
© 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Background: Primaquine is the only widely used drug that prevents Plasmodium vivax malaria relapses, but adherence to the standard 14-day regimen is poor. We aimed to assess the efficacy of a...
Saved in:
Similar Items
-
Disseminating clinical study results to trial participants in Ethiopia: Insights and lessons learned
by: Tamiru S. Degaga, et al.
Published: (2020) -
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)
by: Kamala Thriemer, et al.
Published: (2022) -
Asuhan Keperawatan Risiko Cidera Pada Pasien Epilepsi
by: Mohammad Fahmi Wahyudi
Published: (2020) -
Hubungan Antara Asupan, Status Gizi, Risiko Anemia, Serta Ketahanan Pangan Dengan Produktivitas Kerja Pada Pekerja Bangunan di Wilayah Surabaya Barat
by: Mohammad Fahmi Rasyidi, -
Published: (2020) -
Program Gizi Anak Sekolah (PGAS) Di SDN Jombok I Jombang
by: Mohammad Fahmi Rasyidi, -
Published: (2019)